Clinical trial Recruiting at 1 site Interventional Ages 18 to 80 Women only

Comparing surgical techniques for improving breast skin sensitivity after reconstruction

Official title: Sensory Restoration in DIEP Free Flaps for Post-Mastectomy Breast Reconstruction After Breast Cancer: Comparing Non-sensitized Standard Technique to Direct Nerve Suture and to Autograft: A Three-arm, Randomized, Double-blinded Superiority Trial

Run by University Hospital, Geneva · NCT06930378 · Data updated 2026-11-12

This study is testing if using special nerve stitches during breast reconstruction can help improve skin sensitivity for women who have had surgery for breast cancer or genetic conditions.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexWomen only
Enrollment63 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Geneva, Canton of Geneva)
StatusRecruiting
StartedApril 2025
Main results expectedFebruary 2028
Study endsFebruary 2029
Registry record updatedApril 16, 2025
Trial IDNCT06930378 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 to 80 who are undergoing unilateral DIEP flap breast reconstruction.

Probably not a fit

Patients who have undergone postoperative radiotherapy on the flap or have severe neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of nerve sutures in enhancing skin sensitivity in patients undergoing DIEP flap breast reconstruction due to breast cancer or genetic conditions. Participants aged 18 to 80 will be randomized into three groups: one receiving direct nerve sutures, another receiving an autograft, and a control group with no nerve sutures. The primary outcome will be assessed through sensory testing at 12 months post-surgery, alongside quality of life questionnaires and skin biopsies for proteomic analysis. The goal is to establish a standard method for sensitized flap-based breast reconstruction.

Why it matters

Potential benefit: If successful, this study could significantly improve sensory recovery and quality of life for patients undergoing breast reconstruction.

How similar studies have gone: While the approach of nerve sutures in breast reconstruction is innovative, no previous studies have specifically analyzed the sensory recovery in this context, making this a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
A) Pilot study

Inclusion criteria:

* 18-80 years old
* having received DIEP flap breast reconstruction with a flap not completely buried
* having given written informed consent for participating in the study

Exclusion criteria:

* postoperative radiotherapy on the flap
* neurological conditions as diabetic neuropathy, alcoholism or any other severe underlying peripheral neuropathy including chemotherapy-induced neuropathy or neuropathy induced by other medications
* active smoking
* language barrier
* pregnancy or lactating women

B) Main study

Inclusion Criteria:

* 18 to 80 years old
* having given written informed consent for participating in the study
* receiving immediate or delayed unilateral DIEP breast reconstruction with a DIEP flap which will not be completely buried

Exclusion Criteria:

* autologous reconstruction where the flap is completely buried
* patients in need of both-sided reconstruction (double DIEP)
* postoperative radiotherapy on the flap
* neurological conditions as diabetic neuropathy, alcoholism, or any other severe underlying peripheral neuropathy including chemotherapy-induced neuropathy or neuropathy induced by other medications
* active smoking
* language barrier
* pregnancy at time of planned DIEP flap surgery and lactation

Where it's running

  • Geneva University Hospitals
    Geneva, Canton of Geneva, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Patricia E Engels, MD — University Hospital, Geneva
  • Study coordinator: Patricia E Engels, MD
  • Email: patricia.engels@hug.ch
  • Phone: +41795537557

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.